Synaffix B.V., a Lonza company (SIX: LONN) focused on commercializing its clinical-stage platform technology for …
![Synaffix ABL Bio Partnership](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2023/09/pexels-cottonbro-studio-3952241.jpg?resize=760%2C427&ssl=1)
![Synaffix ABL Bio Partnership](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2023/09/pexels-cottonbro-studio-3952241.jpg?resize=760%2C427&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
Synaffix B.V., a Lonza company (SIX: LONN) focused on commercializing its clinical-stage platform technology for …